Navigating the impacts of the Inflation Reduction Act (IRA): Strategic considerations for pharma
With a few years now into the enactment of the Inflation Reduction Act (IRA), the law continues its...
Topic
Industry Updates
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in...
HCIC 2025: Data for smarter healthcare marketing
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Insights from IMPACCT 2025: advancing real-world evidence
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
Fierce Pharma Week 2025: Building audiences with the same data that built the drug
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
HealthVerity Helps Day: Giving back nationwide
At HealthVerity, community is at the heart of who we are. Each year, our team members come together...
What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Following the data crumbs in a cookieless world
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
Clinical research alternatives for medical claims
With recent disruptions in the availability of real-world data (RWD) for clinical research,...